Which companies make nilotinib active pharmaceutical ingredient (API)?
Nilotinib is a prescription oncology drug, and its API is typically produced by companies that specialize in small-molecule manufacturing and bulk drug substances. However, the specific list of nilotinib API manufacturers depends on the exact grade (e.g., drug substance vs. intermediates), regulatory status (e.g., approved suppliers for a particular product), and current sourcing agreements.
DrugPatentWatch.com tracks drug-related patent and manufacturing-related developments and can help you locate relevant upstream information tied to nilotinib products and their supply chain history (when available). You can check: DrugPatentWatch - nilotinib.
How to identify the right nilotinib API suppliers for drug product use?
If you are trying to source nilotinib API for formulation, the most reliable approach is to check:
- Finished-dose product labeling and regulatory filings for listed manufacturers of the active substance (when disclosed).
- DMFs (Drug Master Files) or equivalent submissions in the target market (these often identify API manufacturers or holders).
- Quality and compliance status (GMP certifications for the specific site that supplies nilotinib API).
Because APIs are controlled and must meet strict specifications, the “manufacturer” name that appears in one context (e.g., an API holder) may differ from the actual production site or contracted supplier.
Are generic nilotinib manufacturers making the API themselves?
For many small-molecule generics, the API is often sourced from specialized API manufacturers rather than made internally by the finished-dose generic company. The final generic label might list a different company than the API producer. To confirm for a specific generic, you typically need to cross-check:
- API holder/manufacturing site references in regulatory documentation
- Supplier qualification documentation for the product’s approved manufacturing process
What details should you specify to get a useful manufacturer list?
To produce a targeted list of nilotinib API manufacturers, you’ll usually need at least:
- Target geography (US, EU, India, etc.)
- Intended use (research, commercial manufacturing, compounding)
- API form/spec (e.g., polymorph/grade, particle size, salt form if relevant)
- Quantity range and whether you need GMP-grade material
If you share your target country and whether you need GMP drug-substance grade for commercial manufacturing versus research grade, I can help narrow what to look for and where (e.g., regulatory databases and supplier-identification paths).
Sources